Cytogenetic Features and Clinical Outcomes of Patients With Non-Secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2019.09.624
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Treatment of Multiple Myeloma in Akita: Features and Outcomes in the Era of Novel Agents

Journal of clinical and experimental hematopathology : JCEH
Medicine
2014English

Clinical Implications of Cytogenetic Heterogeneity in Multiple Myeloma Patients With TP53 Deletion

Modern Pathology
Forensic MedicinePathology
2017English

Non-Secretory Multiple Myeloma With Extramedulary Plasmocytoma

Bangabandhu Sheikh Mujib Medical University Journal
2016English

Induction Therapy and Stem Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma

Stem Cells International
Cell BiologyMolecular Biology
2012English

Value of Novel Agents and Intensive Therapy for Patients With Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2013English

Cytogenetic Study of 48 Patients With Multiple Myeloma and Related Disorders

Journal of clinical and experimental hematopathology : JCEH
Medicine
2003English

Non Secretory Multiple Myeloma – A Case Report

Medical Journal of Indonesia
Medicine
2007English

Differences in the Distribution of Cytogenetic Subtypes Between Multiple Myeloma Patients With and Without a Family History of Monoclonal Gammopathy and Multiple Myeloma

European Journal of Haematology
MedicineHematology
2013English

Cytogenetic and Interphase Fluorescence in Situ Hybridization Studies in Patients With Multiple Myeloma

Molecular Cytogenetics
BiochemistryMolecular MedicineGeneticsMolecular Biology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy